Michael G. Kelly, PhD: President & CEO, Director, Co-Founder
Member TACT, Scientific Advisor and Former CSO, CureDuchenne
Former President, Renovis, Inc. (Evotec), multiple R&D positons at Amgen, Wyeth (Pfizer), GSK
John Kincaid: Director, Co-Founder
Former VP and Managing Director, Synterys, Inc.
Former Director, Drug Discovery, Renovis, Inc. (Evotec), multiple R&D positions at Amgen, ImClone Systems (Lilly), Abbott
Mark P. de Souza, PhD: COO, Director, Co-Founder
Executive Chairman, PellePharm; President & CEO, Chromaderm and FIBRX Tissue Repair.
Former Founding President & CEO, Lotus Tissue Repair, (Shire) and VP Business Development, Dyax (Shire)
Giles Campion, MD: Chief Medical Officer
CMO, Albumedix, Ltd.
Former CMO, Prosensa (Biomarin). Multiple VP positions at GE Healthcare, Novartis, SmithKline Beecham
Chris O’Mara, MS: Sr. Clinical Trial Manager
Former Clinical Trials Specialist, Ultragenyx, Inc.
Former Senior Clinical Research Coordinator, University of California, San Francisco